CD163 and Hepatitis: Under this assumption, sCD163 showed a good performance (AUROC: 0.808) related to hepatitis severity in HCV/HIV coinfected patients; however, despite the observed association between sCD163 and inflammation severity in MAFLD patients it did not display a good performance (Table 2).